title: Severe colitis while responding to ipilimumab in metastatic melanoma.
authors.forename: Marije
authors.initials: M
authors.lastname: Slingerland
authors.forename: Johan W R
authors.initials: JW
authors.lastname: Nortier
authors.forename: Roeland A
authors.initials: RA
authors.lastname: Veenendaal
authors.forename: Ellen
authors.initials: E
authors.lastname: Kapiteijn
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003092:Colitis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D000074324:Ipilimumab; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011379:Prognosis
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab